Long-term Outcome and Prognostic Factor Analysis for Nasopharyngeal Carcinoma Patients Receiving 3DCRT/IMRT in Nonendemic Area of China
J. Zang,L. Zhao,M. Shi,Y. J. Hitchcock
DOI: https://doi.org/10.1016/j.ijrobp.2015.07.1289
2015-01-01
Abstract:Although prognostic factors of nasopharyngeal carcinoma (NPC) have been studied extensively, most of data of these studies are from an endemic area; databases from nonendemic areas are rare. The purpose of this study is to investigate the long-term outcome and prognostic factors analysis for NPC patients receiving 3-dimensional conformal radiation therapy/intensity modulated radiation therapy (3DCRT/IMRT) in a nonendemic area of China. Between January 2004 and December 2011, a total of 393 nonmetastatic and histologically proven NPC patients were identified. All patients received 3DCRT or IMRT. The prognostic factors we analyzed included age, T stage, N stage, lymph node diameter, tumor volume, WHO histology types, and cranial nerve-related symptoms. All patients were staged according to the 7th edition of the American Joint Committee on Cancer (AJCC) system. Factors found to be associated with the endpoints by univariate analyses and then entered into multivariate Cox proportional hazards regression analysis. Continuous variables were divided into 2 subgroups at cut-off values identified by receiver operating characteristic curves and then analyzed. The median follow-up time was 58.3 months (range: 4-130 months). For all patients, the 5-year overall survival (OS), progression-free survival (PFS), locoregional-free survival (LRFS), and distant metastatic-free survival (DMFS) were 71.2%, 60.6%, 84.2%, and 71.6%, respectively. Univariate analyses showed that the risk factors for OS, PFS, and DMFS included T stage (T1-2 vs T3-4), N stage (N0-1 vs N2-3), lymph node diameter (≥3 cm vs <3 cm), cranial nerve symptoms (with vs without), tumor volume (≤40 mL vs >40 mL) and WHO histology types (WHO II vs WHO III). Multivariate analysis indicated that N stage, WHO pathologic types, and tumor volume were 3 independent prognostic factors for OS, PFS, and DMFS. We identified 3 subgroups according to the number of independent risk factors: group 1 (patients with no risk factor), group 2 (patients with only 1 risk factor) and group 3 (patients with more than 2 risk factors). The 5-year OS, PFS, and DMFS for group 1 versus group 2 versus group 3 were 91.5% versus 75.2% versus 49.3%, 82.6% versus 63.5% versus 39.8% and 89.4% versus 77.9% versus 49.4%, respectively (all P<.05) in all patients. N stage, WHO histology types, and tumor volume are independent prognostic indicators for survival outcomes in NPC patients from a nonendemic area of China.